Skip to main content
GuidehouseGuidehouse
Guidehouse
  • Industries
    All Industries
    Industries
    • Communities, Energy & Infrastructure
    • Defense & Security
    • Financial Services
    • Health
    • State & Local Government
    Europe, Middle East & Canada

    Europe, Middle East & CanadaShaping industries with global scale

  • Services
    All Services
    Services
    • AI & Data
    • Energy & Resilience
    • Finance & Revenue
    • Managed Services
    • Mission Enablement
    • Operations & Efficiency
    • People, Organization & Change
    • Risk, Regulatory & Compliance
    • Technology
  • Insights
    All Insights
    Insights
    2026 Trends Guide
    • Energy Providers
    • Government Agencies
    • Financial Services
    • Health
    featured content

    The GuideLine podcast: Finding balance through fast tech and high stakes

  • Careers
    All Careers
    Careers
    • Early Career
    • Contractors
    • Experienced Professionals
    • Veterans & Military
    Help Guide the Future

    Search & Apply for Jobs

  • About
    About Guidehouse
    About
    • Community Impact
    • Government Contract Vehicles
    • D.C. United Partnership
    • Ecosystem Partners
    • Europe, Middle East & Canada
    • Legal
    • News & Events
    • Leadership
    • Privacy Policy
    Guidehouse in
    DeutschlandIndiaLietuvaUnited KingdomView offices
Patient support programs trends 2025 Survey Report AdobeStock_1185107043-hero small Patient support programs (PSPs) are a critical bridge between pharmaceutical manufacturers, providers, payers, and patients. Through provider and patient education, affordability initiatives, digital health platforms, and other important services, PSPs ensure that therapies get to patients who need them and are taken properly and consistently. In a recent Guidehouse survey, pharmaceutical executives said that these programs are playing a critical role in helping patients afford their medication and have a positive experience. But leaders also cautioned that the industry needs to invest in improving the effectiveness of PSPs, especially those that serve at-risk populations and help providers with an often-complicated reimbursement process. Download the report HUB Services of respondents say HUB services are used by at least half of patients enrolled in PSPs 59% Copay Assistance of patients enrolled in a PSP participate in a copay assistance program 80% At Risk Pop Improvements of respondents say programs that serve at-risk populations need improvement 52% Report insights Guidehouse is a global AI-led professional services firm delivering advisory, technology, and managed services to the commercial and government sectors. With an integrated business technology approach, Guidehouse drives efficiency and resilience in the healthcare, financial services, energy, infrastructure, and national security markets. Let us guide you Error: Email is required Error: Industry is required Error: Please use the example@domain.com format Communities Energy and Infrastructure CEI Communities, Energy & Infrastructure Defense and Security DS Defense & Security Financial Services FS Health and Life Sciences HC Health & Life Sciences State and Local Government SLG State & Local Government Other Industries Other Industry - Please Select Your Work Email Get in touch with our experts:
AdobeStock_1185107043-hero smallAdobeStock_1185107043-tablet-1024x920AdobeStock_1185107043-mobile-428x332
2025 Survey Report

Patient support
programs trends

Patient support programs (PSPs) are a critical bridge between pharmaceutical manufacturers, providers, payers, and patients. Through provider and patient education, affordability initiatives, digital health platforms, and other important services, PSPs ensure that therapies get to patients who need them and are taken properly and consistently.

In a recent Guidehouse survey, pharmaceutical executives said that these programs are playing a critical role in helping patients afford their medication and have a positive experience. But leaders also cautioned that the industry needs to invest in improving the effectiveness of PSPs, especially those that serve at-risk populations and help providers with an often-complicated reimbursement process.
Download the report

Report insights

59%of respondents say HUB services are used by at least half of patients enrolled in PSPs

80%of patients enrolled in a PSP participate in a copay assistance program

52%of respondents say programs that serve at-risk populations need improvement

Meet our experts

john etchberger

John
Etchberger, Ph.D.

Partner, Life Sciences

John supports biopharma organizations by defining cross-functional commercialization strategies that drive growth and ensure successful product launches, aligning teams for optimal market success.

Jacob Graham headshot

Jacob
Graham

Partner, Life Sciences

Jacob leads a team dedicated to market access strategy design and implementation for disruptive life science innovations.

Let us guide you

Guidehouse is a global AI-led professional services firm delivering advisory, technology, and managed services to the commercial and government sectors. With an integrated business technology approach, Guidehouse drives efficiency and resilience in the healthcare, financial services, energy, infrastructure, and national security markets.

Get in touch with our experts:

  • Privacy Notice for CA Residents
  • Modern Slavery Statement
  • Do Not Sell / Share My Personal Information
  • Cookie Settings & Do Not Sell My Personal Info
  • Global Human Rights Statement

© 2026 Guidehouse